NCT07143747View on ClinicalTrials.gov

PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

December 31, 2028

Conditions
Mild Asthma
Interventions
OTHER

Hyperpolarized 129Xe MRI

Inhalation of hyperpolarized 129Xe gas followed by breath-hold MRI for ventilation imaging.

OTHER

Tc-99m Technegas Ventilation Imaging

Inhalation of Tc-99m-labeled carbon aerosol (Technegas) followed by SPECT imaging to assess lung ventilation.

Trial Locations (1)

N6A 5B7

Robarts Research Institute; The University of Western Ontario, London

All Listed Sponsors
collaborator

Cyclomedica Australia PTY Limited

INDUSTRY

lead

Dr. Grace Parraga

OTHER

NCT07143747 - PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging) | Biotech Hunter | Biotech Hunter